
Adverse Events Associated with Apremilast and Deucravacitinib for Psoriasis: A Pharmacovigilance Study Based on the ...
Introduction Psoriasis is a chronic, immune-mediated, inflammatory cutaneous disease, affecting over 100 million adults and children worldwide.1,2 Plaque psoriasis (PsO), characterized by erythematous scaly patches and plaques, is the most common phenotype …